Purvalanol B
CAS: 212844-54-7
Ref. 3D-MIA84454
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- 2-Chloro-4-[(2-{[(2R)-1-hydroxy-3-methylbutan-2-yl]amino}-9-isopropyl-9H-purin-6-yl)amino]benzoic acid
- 2-Chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]benzoic acid
- Benzoic acid, 2-chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]-
- Ng 95
Purvalanol B is a kinase inhibitor that targets the apoptosis pathway. Its mechanism of action is to inhibit the production of proteins that are involved in the apoptosis pathway, such as bcl-2 protein. Purvalanol B has been shown to inhibit cancer cells by blocking the nuclear DNA response element, which inhibits transcription and replication of cancerous cells. It also inhibits the production of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α). This drug also works by inhibiting inhibitors of apoptosis proteins, such as bcl-2 and bax.
Propiedades químicas
Consulta técnica sobre: 3D-MIA84454 Purvalanol B
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
